Premier Path Wealth Partners LLC Has $549,000 Stake in Veeva Systems Inc. $VEEV

Premier Path Wealth Partners LLC grew its position in Veeva Systems Inc. (NYSE:VEEV) by 12.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,907 shares of the technology company’s stock after purchasing an additional 205 shares during the quarter. Premier Path Wealth Partners LLC’s holdings in Veeva Systems were worth $549,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Crossmark Global Holdings Inc. bought a new position in shares of Veeva Systems in the first quarter valued at approximately $299,000. Private Trust Co. NA raised its position in shares of Veeva Systems by 35.0% in the first quarter. Private Trust Co. NA now owns 247 shares of the technology company’s stock valued at $57,000 after purchasing an additional 64 shares during the period. Merit Financial Group LLC raised its position in shares of Veeva Systems by 12.5% in the second quarter. Merit Financial Group LLC now owns 45,247 shares of the technology company’s stock valued at $13,030,000 after purchasing an additional 5,042 shares during the period. QRG Capital Management Inc. increased its position in Veeva Systems by 15.7% during the second quarter. QRG Capital Management Inc. now owns 12,771 shares of the technology company’s stock worth $3,678,000 after acquiring an additional 1,735 shares during the period. Finally, Amalgamated Bank increased its position in Veeva Systems by 5.0% during the first quarter. Amalgamated Bank now owns 10,949 shares of the technology company’s stock worth $2,536,000 after acquiring an additional 520 shares during the period. Institutional investors own 88.20% of the company’s stock.

Veeva Systems Stock Down 0.4%

Shares of NYSE VEEV opened at $285.40 on Friday. The firm’s 50-day simple moving average is $285.22 and its 200 day simple moving average is $271.73. The company has a market cap of $46.78 billion, a price-to-earnings ratio of 58.60, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 12-month low of $201.54 and a 12-month high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). The company had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm’s quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the company earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, equities analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Insider Buying and Selling

In other Veeva Systems news, insider Eleni Nitsa Zuppas sold 6,000 shares of the company’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the transaction, the insider directly owned 25,325 shares in the company, valued at approximately $7,765,151.50. This represents a 19.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Thomas D. Schwenger sold 3,350 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the transaction, the insider owned 23,773 shares in the company, valued at approximately $7,132,850.92. The trade was a 12.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 24,665 shares of company stock worth $7,438,000 in the last 90 days. Corporate insiders own 10.30% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on VEEV shares. Piper Sandler boosted their target price on shares of Veeva Systems from $325.00 to $355.00 and gave the stock an “overweight” rating in a research report on Thursday, August 28th. Truist Financial lifted their price objective on Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a report on Thursday, August 28th. TD Cowen raised Veeva Systems from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $297.00 to $380.00 in a report on Tuesday, October 7th. Stifel Nicolaus lifted their price objective on Veeva Systems from $295.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, August 28th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $340.00 price target (up previously from $310.00) on shares of Veeva Systems in a report on Thursday, August 28th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Veeva Systems has an average rating of “Moderate Buy” and a consensus target price of $307.58.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.